Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E L Grove

Showing results (11-20 of 21) with videos related to

Pageof 3
Sort By:
Journal of Thrombosis and Haemostasis : JTH|April 20, 2011
Increased platelet turnover in patients with previous definite stent thrombosisE L Grove, M Würtz, A-M Hvas, et al.
Thrombosis and Haemostasis|February 15, 2013
Reduced antiplatelet effect of aspirin is associated with low-grade inflammation in patients with coronary artery diseaseS B Larsen, E L Grove, S D Kristensen, et al.
Journal of Thrombosis and Haemostasis : JTH|October 20, 2010
Effect of platelet turnover on whole blood platelet aggregation in patients with coronary artery diseaseE L Grove, A M Hvas, S B Mortensen, et al.
Journal of Internal Medicine|May 19, 2004
The platelet polymorphism PlA2 is a genetic risk factor for myocardial infarctionE L Grove, T F Ørntoft, J F Lassen, et al.
Thrombosis Research|May 11, 2010
Reduced platelet response to aspirin in patients with coronary artery disease and type 2 diabetes mellitusS B Mortensen, S B Larsen, E L Grove, et al.
Journal of Internal Medicine|May 4, 2016
Preadmission use of selective serotonin reuptake inhibitors and short-term mortality in diabetic patients hospitalized due to strokeM Würtz, M Schmidt, E L Grove, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|April 22, 2019
Differential vascular effects of aspirin in people with Type 2 diabetes without cardiovascular disease and matched controls without diabetesL Vernstrøm, E Laugesen, E L Grove, et al.
Journal of Thrombosis and Haemostasis : JTH|February 8, 2013
Prolonged outpatient vitamin K antagonist use and risk of venous thromboembolism in patients undergoing total hip or knee replacementA Lalmohamed, P Vestergaard, P A F Jansen, et al.
Thrombosis and Haemostasis|September 5, 2014
The influence of type 2 diabetes on fibrin clot properties in patients with coronary artery diseaseS Neergaard-Petersen, A-M Hvas, S D Kristensen, et al.
Thrombosis Research|February 19, 2019
A changing landscape: Temporal trends in incidence and characteristics of patients hospitalized with venous thromboembolism 2006-2015A M Münster, T B Rasmussen, A M Falstie-Jensen, et al.
Pageof 3

Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Journal of Thrombosis and Haemostasis : JTH|April 20, 2011
Increased platelet turnover in patients with previous definite stent thrombosisE L Grove, M Würtz, A-M Hvas, et al.
Thrombosis and Haemostasis|February 15, 2013
Reduced antiplatelet effect of aspirin is associated with low-grade inflammation in patients with coronary artery diseaseS B Larsen, E L Grove, S D Kristensen, et al.
Journal of Thrombosis and Haemostasis : JTH|October 20, 2010
Effect of platelet turnover on whole blood platelet aggregation in patients with coronary artery diseaseE L Grove, A M Hvas, S B Mortensen, et al.
Journal of Internal Medicine|May 19, 2004
The platelet polymorphism PlA2 is a genetic risk factor for myocardial infarctionE L Grove, T F Ørntoft, J F Lassen, et al.
Thrombosis Research|May 11, 2010
Reduced platelet response to aspirin in patients with coronary artery disease and type 2 diabetes mellitusS B Mortensen, S B Larsen, E L Grove, et al.
Journal of Internal Medicine|May 4, 2016
Preadmission use of selective serotonin reuptake inhibitors and short-term mortality in diabetic patients hospitalized due to strokeM Würtz, M Schmidt, E L Grove, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|April 22, 2019
Differential vascular effects of aspirin in people with Type 2 diabetes without cardiovascular disease and matched controls without diabetesL Vernstrøm, E Laugesen, E L Grove, et al.
Journal of Thrombosis and Haemostasis : JTH|February 8, 2013
Prolonged outpatient vitamin K antagonist use and risk of venous thromboembolism in patients undergoing total hip or knee replacementA Lalmohamed, P Vestergaard, P A F Jansen, et al.
Thrombosis and Haemostasis|September 5, 2014
The influence of type 2 diabetes on fibrin clot properties in patients with coronary artery diseaseS Neergaard-Petersen, A-M Hvas, S D Kristensen, et al.
Thrombosis Research|February 19, 2019
A changing landscape: Temporal trends in incidence and characteristics of patients hospitalized with venous thromboembolism 2006-2015A M Münster, T B Rasmussen, A M Falstie-Jensen, et al.
Pageof 3